Diaclone

Anti-Human CD40 Monoclonal Antibody,Unconjugated Clone B-B20

Product Code:
 
854.283.020
Product Group:
 
Primary Antibodies
Supplier:
 
Diaclone
Host Type:
 
Mouse
Antibody Isotype:
 
IgG1
Antibody Clonality:
 
Monoclonal
Antibody Clone:
 
B-B20
Regulatory Status:
 
RUO
Target Species:
 
Human
Application:
 
Flow Cytometry
Storage:
 
Stable at +2-8°C for 12 months. For longer storage freeze aliquots
 

No additional charges, what you see is what you pay! *

CodeSizePrice
854.283.020200 tests/2ml£214.00
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: France.
Typical lead time: 14-21 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Antigen:
CD40
Conjugate:
Purified
Format:
Phosphate-buffered saline with 1% BSA and 0.09% sodium azide
Hybridoma:
Myeloma X63/AG.8653 x Balb/c spleen cells
Immunisation:
Raji cell line
Reactivity:
Human
Research Area:
B Cell Antigens,CD Markers
Specificity:
Recognises the Bp50 antigen, a 48 kDa protein
Working Dilution:
Use 10 µl to label 106 cells or 100 µl of whole blood
Workshop:
VI

References

  1. Moutaftsi M. et al., Blood, 2002; 99(8): 2913 - 2921. Human cytomegalovirus inhibits maturation and impairs function of monocyte-derived dendritic cells. https://www.ncbi.nlm.nih.gov/pubmed/11929782
  2. Spirig, R. et al, J. Immunol.,2008; 181(2): 878-890.. The Complement Inhibitor Low Molecular Weight Dextran Sulfate Prevents TLR4-Induced Phenotypic and Functional Maturation of Human Dendritic Cells. https://www.ncbi.nlm.nih.gov/pubmed/18606639
  3. Spirig, R. et al.,PLoS One,2010; 5(6): e0010983.. Effects of TLR agonists on the hypoxia-regulated transcription factor HIF-1alpha and dendritic cell maturation under normoxic conditions.. https://www.ncbi.nlm.nih.gov/pubmed/20539755
  4. Wassmer, S. C. et al., PLoS Med.,2005;2(9): e245.. Inhibition of endothelial activation: a new way to treat cerebral malaria?. https://www.ncbi.nlm.nih.gov/pubmed/16104828